Ctrl

K

Table of contents

Expand All Topics

Pulmonary hypertension of sickle cell disease

Guidelines

Key sources

The following summarized guidelines for the management of pulmonary hypertension of sickle cell disease are prepared by our editorial team based on guidelines from the American Thoracic Society (ATS 2014).
1

Medical management

Hydroxyurea: as per ATS 2014 guidelines, initiate hydroxyurea therapy in patients with sickle cell disease who are at increased risk for mortality.
B
Create free account

More topics in this section

  • Phosphodiesterase inhibitors

  • Prostacyclin agonists and endothelin receptor antagonists

  • PAH-targeted therapy

  • Anticoagulant therapy

Therapeutic procedures

Chronic transfusion: as per ATS 2014 guidelines, consider initiating chronic transfusion therapy in patients with sickle cell disease who have an increased risk for mortality and who do not respond to hydroxyurea or not candidates for hydroxyurea.
C
Create free account